Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Salbutamol sulfate 0.482 mg/mL (eqv to 0.4mg/mL of salbutamol)
AFT Pharmaceuticals Ltd
Salbutamol sulfate 0.482 mg/mL (eqv to 0.4mg/mL of salbutamol)
2 mg/5mL
Syrup
Active: Salbutamol sulfate 0.482 mg/mL (eqv to 0.4mg/mL of salbutamol) Excipient: Citric acid monohydrate Glycerol Purified water Raspberry flavour 517503E Saccharin sodium Sodium benzoate Sodium citrate dihydrate Xanthan gum
Bottle, glass, Amber, Type III glass with pilfer proof aluminium cap, 150 mL
Prescription
Prescription
Sicor (Societa Italiana Corticosteroidi) Srl
Salapin is indicated for relief of bronchospasm in bronchial asthma of all types, chronic bronchitis and emphysema. Salapin is suitable oral therapy for children or those adults who prefer liquid medicines.
Package - Contents - Shelf Life: Bottle, glass, Amber, Type III glass with pilfer proof aluminium cap - 150 mL - 36 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE with PE CRC cap - 150 mL - 36 months from date of manufacture stored at or below 25°C
2002-08-23
SALAPIN SALBUTAMOL SYRUP 2MG/5ML QUALITATIVE AND QUANTITATIVE COMPOSITION Salapin: Salbutamol BP 2mg as sulphate in each 5mL of a raspberry cola flavoured, sugar free syrup. CLINICAL PARTICULARS _THERAPEUTIC INDICATIONS _ Salbutamol is a selective β 2 adrenoceptor agonist. At therapeutic doses it acts on the β 2 adrenoceptors of bronchial muscle, with little or no action on the β-1 adrenoceptors of the heart. It is suitable for the management and prevention of attack in asthma. Bronchodilators should not be the only or main treatment in patients with severe or unstable asthma. Severe asthma requires regular medical assessment as death may occur. Patients with severe asthma have constant symptoms and frequent exacerbations, with limited physical capacity, and PEF values below 60% predicted at baseline with greater than 30% variability, usually not returning entirely to normal after a bronchodilator. These patients will require high dose inhaled (eg >1mg/day beclomethasone dipropionate) or oral corticosteroid therapy. Sudden worsening of symptoms may require increased corticosteroid dosage which should be administered under urgent medical supervision. Salapin is indicated for relief of bronchospasm in bronchial asthma of all types, chronic bronchitis and emphysema. Salapin is suitable oral therapy for children or those adults who prefer liquid medicines. _POSOLOGY AND METHOD OF ADMINISTRATION _ Salbutamol has a duration of action of 4 to 6 hours in most patients. Increasing use of β 2 agonists may be a sign of worsening asthma. Under these conditions a reassessment of the patient's therapy plan may be required and concomitant glucocorticosteroid therapy should be considered. As there may be adverse effects associated with excessive dosing, the dosage or frequency of administration should only be increased on medical advice. ADULTS: The usual effective dose is 10mL salbutamol (4 milligrams of salbutamol) three or four times per day. If adequate bronchodilation is not obtained each single dose may be gradually in Read the complete document